The problem is obtaining knowledge: a qualitative analysis of provider barriers and accelerators to rapid adoption of new treatment in a public health emergency

Abstract Granted by the U.S. Food and Drug Administration, an Emergency Use Authorization (EUA) can only be utilized upon declaration that a specialized set of circumstances exist which justify the authorization. In 2020, the COVID-19 pandemic demanded rapid communication strategies to promote treat...

Full description

Bibliographic Details
Main Authors: Stuart H. Williams, Megan D. McFarlane, Mary Giammarino, Jamie Oleksa
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-022-14890-3